FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2071962007> ?p ?o ?g. }

• W2071962007 endingPage "869" @default.
• W2071962007 startingPage "862" @default.
• W2071962007 abstract "The thioether phospholipid ilmofosine (BM 41 440) is a new anti-cancer drug presently undergoing phase II clinical trials. Because resistance to anti-tumour drugs is a major problem in cancer treatment, we investigated the resistance of different cell lines to this compound. Here we report that the multidrug-resistant cell lines MCF7/ADR, CCRFNCR1000, CCRF/ADR500, CEM/VLB100 and HeLa cell lines transfected with a wild-type and mutated (gly/val185) multidrug resistance 1 gene (MDR1) are cross-resistant to ilmofosine compared with the sensitive parental cell lines. In CEMNM-1 cells, in which the resistance is associated with an altered topoisomerase II gene, no cross-resistance to ilmofosine was observed. Ilmofosine is not capable of modulating multidrug resistance and neither does it reduce the labelling of the P-glycoprotein (P-gp) by azidopine nor alter ATPase activity significantly. The resistance to ilmofosine in multidrug-resistant CCRF/VCR1000 cells cannot be reversed by the potent multidrug resistance modifier dexniguldipine-HCI (B8509-035). A tenfold excess of ilmofosine does not prevent the MDR-modulating effect of dexniguldipine-HCl. Treatment of cells with ilmofosine does not alter the levels of MDR1 mRNA. Long-term treatment of an ilmofosine-resistant Meth A subline with the drug does not induce multidrug resistance, indicating that ilmofosine does not increase the level of P-gp. Determination of the MDR2 mRNA levels in the cells revealed that the resistance pattern to ilmofosine is not correlated with the expression of this gene. It is concluded, therefore, that multidrug-resistant cells are cross-resistant to ilmofosine and that the compound is not a substrate of Pgp. No association between the expression of the MDR2-encoded P-gp and resistance to ilmofosine was observed. It is supposed that MDR1-associated alterations in membrane lipids cause resistance to ilmofosine." @default.
• W2071962007 created "2016-06-24" @default.
• W2071962007 creator A5009079357 @default.
• W2071962007 creator A5009556973 @default.
• W2071962007 creator A5010476736 @default.
• W2071962007 creator A5018953645 @default.
• W2071962007 creator A5038754244 @default.
• W2071962007 creator A5069424443 @default.
• W2071962007 creator A5073223978 @default.
• W2071962007 creator A5077262700 @default.
• W2071962007 date "1997-10-01" @default.
• W2071962007 modified "2023-10-09" @default.
• W2071962007 title "Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440)" @default.
• W2071962007 cites W1526728285 @default.
• W2071962007 cites W1531911812 @default.
• W2071962007 cites W1539287293 @default.
• W2071962007 cites W1595352454 @default.
• W2071962007 cites W1620132817 @default.
• W2071962007 cites W1957284165 @default.
• W2071962007 cites W1963662073 @default.
• W2071962007 cites W1970958639 @default.
• W2071962007 cites W1976415781 @default.
• W2071962007 cites W1990366181 @default.
• W2071962007 cites W2002244693 @default.
• W2071962007 cites W2027079587 @default.
• W2071962007 cites W2028730118 @default.
• W2071962007 cites W2038758400 @default.
• W2071962007 cites W2042367294 @default.
• W2071962007 cites W2044946913 @default.
• W2071962007 cites W2046404871 @default.
• W2071962007 cites W2048118253 @default.
• W2071962007 cites W2069943574 @default.
• W2071962007 cites W2079699191 @default.
• W2071962007 cites W2081421031 @default.
• W2071962007 cites W2082064626 @default.
• W2071962007 cites W2088025265 @default.
• W2071962007 cites W2091411810 @default.
• W2071962007 cites W2097878215 @default.
• W2071962007 cites W2109689528 @default.
• W2071962007 cites W2118234018 @default.
• W2071962007 cites W2128576160 @default.
• W2071962007 cites W2146855297 @default.
• W2071962007 cites W2172134989 @default.
• W2071962007 cites W2396698353 @default.
• W2071962007 cites W2419326351 @default.
• W2071962007 cites W2442168695 @default.
• W2071962007 doi "https://doi.org/10.1038/bjc.1997.476" @default.
• W2071962007 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2228059" @default.
• W2071962007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9328144" @default.
• W2071962007 hasPublicationYear "1997" @default.
• W2071962007 type Work @default.
• W2071962007 sameAs 2071962007 @default.
• W2071962007 citedByCount "10" @default.
• W2071962007 countsByYear W20719620072012 @default.
• W2071962007 countsByYear W20719620072014 @default.
• W2071962007 crossrefType "journal-article" @default.
• W2071962007 hasAuthorship W2071962007A5009079357 @default.
• W2071962007 hasAuthorship W2071962007A5009556973 @default.
• W2071962007 hasAuthorship W2071962007A5010476736 @default.
• W2071962007 hasAuthorship W2071962007A5018953645 @default.
• W2071962007 hasAuthorship W2071962007A5038754244 @default.
• W2071962007 hasAuthorship W2071962007A5069424443 @default.
• W2071962007 hasAuthorship W2071962007A5073223978 @default.
• W2071962007 hasAuthorship W2071962007A5077262700 @default.
• W2071962007 hasBestOaLocation W20719620072 @default.
• W2071962007 hasConcept C114851261 @default.
• W2071962007 hasConcept C121608353 @default.
• W2071962007 hasConcept C133936738 @default.
• W2071962007 hasConcept C147897179 @default.
• W2071962007 hasConcept C202751555 @default.
• W2071962007 hasConcept C2777366897 @default.
• W2071962007 hasConcept C2778080818 @default.
• W2071962007 hasConcept C2778707650 @default.
• W2071962007 hasConcept C502942594 @default.
• W2071962007 hasConcept C54009773 @default.
• W2071962007 hasConcept C54355233 @default.
• W2071962007 hasConcept C55493867 @default.
• W2071962007 hasConcept C81885089 @default.
• W2071962007 hasConcept C86803240 @default.
• W2071962007 hasConcept C96232424 @default.
• W2071962007 hasConcept C98274493 @default.
• W2071962007 hasConceptScore W2071962007C114851261 @default.
• W2071962007 hasConceptScore W2071962007C121608353 @default.
• W2071962007 hasConceptScore W2071962007C133936738 @default.
• W2071962007 hasConceptScore W2071962007C147897179 @default.
• W2071962007 hasConceptScore W2071962007C202751555 @default.
• W2071962007 hasConceptScore W2071962007C2777366897 @default.
• W2071962007 hasConceptScore W2071962007C2778080818 @default.
• W2071962007 hasConceptScore W2071962007C2778707650 @default.
• W2071962007 hasConceptScore W2071962007C502942594 @default.
• W2071962007 hasConceptScore W2071962007C54009773 @default.
• W2071962007 hasConceptScore W2071962007C54355233 @default.
• W2071962007 hasConceptScore W2071962007C55493867 @default.
• W2071962007 hasConceptScore W2071962007C81885089 @default.
• W2071962007 hasConceptScore W2071962007C86803240 @default.
• W2071962007 hasConceptScore W2071962007C96232424 @default.
• W2071962007 hasConceptScore W2071962007C98274493 @default.
• W2071962007 hasIssue "7" @default.

• next